Cardioprotective Potential of Cymbopogon citratus Essential Oil against Isoproterenol-induced Cardiomyocyte Hypertrophy: Possible Involvement of NLRP3 Inflammasome and Oxidative Phosphorylation Complex Subunits

• Published in: Current medical science Vol. 44; no. 2; pp. 450 - 461
• Main Authors: Ding, Xiao-yun, Zhang, Hao, Qiu, Yu-mei, Xie, Meng-die, Wang, Hu, Xiong, Zheng-yu, Li, Ting-ting, He, Chun-ni, Dong, Wei, Tang, Xi-lan
• Format: Journal Article
• Language: English
• Published: Wuhan Huazhong University of Science and Technology 01.04.2024
• Subjects: Cymbopogon - chemistry; Cymbopogon - metabolism; Hypertrophy - chemically induced; Hypertrophy - drug therapy; Hypertrophy - metabolism; Inflammasomes - metabolism; Isoproterenol; Medicine; Medicine & Public Health; Myocytes, Cardiac - metabolism; NLR Family, Pyrin Domain-Containing 3 Protein; Oils, Volatile - pharmacology; Original Article; Oxidative Phosphorylation; RNA, Messenger - metabolism; oxidative phosphorylation complex subunits; essential oil; cardiac hypertrophy; NLRP3 inflammasome; Cymbopogon citratus essential oil
• ISSN: 2096-5230; 2523-899X; 2523-899X
• DOI: 10.1007/s11596-024-2851-9

Objective Cymbopogon citratus (DC.) Stapf is a medicinal and edible herb that is widely used for the treatment of gastric, nervous and hypertensive disorders. In this study, we investigated the cardioprotective effects and mechanisms of the essential oil, the main active ingredient of Cymbopogon citratus , on isoproterenol (ISO)-induced cardiomyocyte hypertrophy. Methods The compositions of Cymbopogon citratus essential oil (CCEO) were determined by gas chromatography-mass spectrometry. Cardiomyocytes were pretreated with 16.9 µg/L CCEO for 1 h followed by 10 µmol/L ISO for 24 h. Cardiac hypertrophy-related indicators and NLRP3 inflammasome expression were evaluated. Subsequently, transcriptome sequencing (RNA-seq) and target verification were used to further explore the underlying mechanism. Results Our results showed that the CCEO mainly included citronellal (45.66%), geraniol (23.32%), and citronellol (10.37%). CCEO inhibited ISO-induced increases in cell surface area and protein content, as well as the upregulation of fetal gene expression. Moreover, CCEO inhibited ISO-induced NLRP3 inflammasome expression, as evidenced by decreased lactate dehydrogenase content and downregulated mRNA levels of NLRP3, ASC, CASP1, GSDMD , and IL-1β , as well as reduced protein levels of NLRP3, ASC, pro-caspase-1, caspase-1 (p20), GSDMD-FL, GSDMD-N, and pro-IL-1β. The RNA-seq results showed that CCEO inhibited the increase in the mRNA levels of 26 oxidative phosphorylation complex subunits in ISO-treated cardiomyocytes. Our further experiments confirmed that CCEO suppressed ISO-induced upregulation of mt-Nd1, Sdhd, mt-Cytb, Uqcrq, and mt-Atp6 but had no obvious effects on mt-Col expression. Conclusion CCEO inhibits ISO-induced cardiomyocyte hypertrophy through the suppression of NLRP3 inflammasome expression and the regulation of several oxidative phosphorylation complex subunits.